Australia
Herbert Smith Freehills, King & Wood Mallesons and Clayton Utz all have roles on the upcoming $4.8 billion initial public offering of Australian health insurer Medibank Private Ltd. The Australian government is the sole shareholder in the company, which is the country’s largest private health insurer and serves more than 3.8 million customers. Depending on market sentiment, the government has said it will sell all 2.75 billion shares in Medibank at between $1.36 and $1.76 apiece. The final price and trading on the Australian Securities Exchange is expected on Nov. 25. The government will keep all of the proceeds from the IPO, and plans to use the money for infrastructure investment in the country. Herbert Smith Freehills is advising the Australian government on the deal, with a team led by Sydney partner Philippa Stone. King & Wood Mallesons Sydney partner Tim Bednall, along with seven other partners in Sydney and Melbourne, is acting for Medibank. Clayton Utz Sydney partner Stuart Byrne is leading a team acting for joint lead managers Deutsche Bank AG, Goldman Sachs Australia Pty. Ltd. and Macquarie Capital (Australia) Pty. Ltd. [Read full story]
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
